First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: The company's significant revenue decline and operational losses have raised concerns among investors about its long-term viability, despite some positive clinical developments.